A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome

BACKGROUND: We designed this single-centre clinical trial to assess the potential benefits of N-Acetylcysteine (NAC) in patients with COVID19-associated acute respiratory distress syndrome (ARDS). METHODS: Ninety-two patients with mild-to-moderate COVID19-associated ARDS were allocated to the placeb...

Descripción completa

Detalles Bibliográficos
Autores principales: Taher, Abbas, Lashgari, Marjan, Sedighi, Ladan, Rahimi-bashar, Farshid, Poorolajal, Jalal, Mehrpooya, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191712/
https://www.ncbi.nlm.nih.gov/pubmed/34114174
http://dx.doi.org/10.1007/s43440-021-00296-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191712/
https://www.ncbi.nlm.nih.gov/pubmed/34114174
http://dx.doi.org/10.1007/s43440-021-00296-2

Ejemplares similares